Page 22 - Ioscience News Today

Extension of previous funding round brings total raised to £7 million GBP (circa $9.2 million USD) Investment from Calculus Capital, Par Equity, and Scottish Enterprise Funding will

PENTICTON, BC / ACCESSWIRE / April 6, 2022 / EastWest Bioscience Inc. ("EastWest" or "Company") (TSXV:EAST), announced that it has filed its Quarterly Financials and MD&A under its profile on SEDAR with

InFlectis BioScience granted Orphan Drug Designation for IFB-088 (icerguastat), a clinical stage treatment for Amyotrophic Lateral Sclerosis

PENTICTON, BC / ACCESSWIRE / March 23, 2022 / EastWest Bioscience Inc. ("EastWest" or "Company") (TSXV:EAST), reports that, pursuant to the Board of Directors Ancillary Compensation Agreement (the "Compensation

Biolexis will launch AKS-452 as “AmbiVax-CTM” for global markets where the cold chain elimination would contribute to improving immunization coverage and reducing vaccine wastage

In Slovakia, the Hoosiers are planning to meet with non-governmental and civil society organizations to voice Indianas support for Ukraine and Ukrainian refugees following Russias invasion of Ukraine.

Program EPIL-A21-1 will compare effectiveness of FDA-approved Epidiolex to DehydraTECHTM-CBD for reducing seizure activity;DehydraTECH-CBD test articles have been delivered to the laboratory ready to commence

Newest granted patent expands worldwide patent portfolio to 24KELOWNA, BC / ACCESSWIRE / March 8, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator

Seoul [South Korea], February 22 (ANI/Global Economic): As flurona, which means having both COVID-19 and influenza at the same time, is recently popping up in many countries, including Israel, Brazil, the U.S., Hungary, and Croatia, concerns on twindemic have emerged.

Dublin, Feb. 17, 2022 (GLOBE NEWSWIRE) -- The "Global Agricultural Biotechnology for Transgenic Crops Market (2021-2026) by Type, Crop, Geography,...